MyLRC +
SB 46 revise certain provisions relating to controlled...

State of South Dakota  
SEVENTY-SEVENTH SESSION
LEGISLATIVE ASSEMBLY,  2002
 

400H0217  
SENATE HEALTH AND HUMAN SERVICES COMMITTEE ENGROSSED   NO. SB 46   -   01/16/2002  

        Introduced by: The Committee on Health and Human Services at the request of the Department of Health  


         FOR AN ACT ENTITLED, An Act to  revise certain provisions relating to controlled substances.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF SOUTH DAKOTA:
     Section  1.  That § 34-20B-17 be amended to read as follows:
     34-20B-17.   Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, is included in Schedule II, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:
             (1)      Alphaprodine ;
             (2)      Anileridine ;
             (3)      Bezitramide ;
             (4)      Diphenoxylate ;
             (5)      Fentanyl ;
             (6)      Isomethadone ;
             (7)      Levomethorphan ;
             (8)      Levorphanol ;
             (9)      Metazocine ;
             (10)      Methadone ;
             (11)      Methadone-intermediate, 4-cyano-2-dimethylamine-1, 4-diphenyl butane ;
             (12)      Moramide-intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid ;
             (13)      Pethidine ;
             (14)      Pethidine-intermediate, A, 4-cyano-1-methyl-4-phenylpiperidine ;
             (15)      Pethidine-intermediate, B, ethyl-4-phenylpiperidine-4-carboxylate ;
             (16)      Pethidine-intermediate, C, 1-methyl-4-phenylpiperidine- 4-carboxylic acid ;
             (17)      Phenazocine ;
             (18)      Piminodine ;
             (19)      Racemethorphan ;
             (20)      Racemorphan ;
             (21)      Sufentanil ;
             (22)      Alfentanil ;
             (23)      Carfentanil ;
             (24)      Levo-alphacetylmethadol, also known as levo-alpha- acetylmethadyl acetate or LAAM ;
             (25)    Remifentanil .
     Section  2.  That § 34-20B-25 be amended to read as follows:
     34-20B-25.   The following are included in Schedule IV:
             (1)      Chlordiazepoxide, but not including librax (chlordiazepoxide hydrochloride and

clindinium bromide) or menrium (chlordiazepoxide and water soluble esterified estrogens);

             (2)      Clonazepam;
             (3)      Clorazepate;
             (4)      Diazepam;
             (4A)      Flunitrazepam;
             (5)      Flurazepam;
             (6)      Mebutamate;
             (7)      Oxazepam;
             (8)      Prazepam;
             (9)      Lorazepam;
             (10)      Triazolam;
             (11)      Any substance which contains any quantity of a benzodiazepine, or salt of benzodiazepine, except those substances which are specifically listed in other schedules;
             (12)      Buprenorphine;
             (13)      Cathine;
             (14)      Fencamfamine;
             (15)      Fenproporex;
             (16)      Mefenorex;
             (17)      Pyrovalerone;
             (18)      Propoxyphene;
             (19)      Pentazocine;
             (20)      Diethylpropion;
             (21)      Ethchlorvynol;
             (22)      Ethinamate;
             (23)      Fenfluramine;
             (24)      Mazindol;
             (25)      Mephobarbital;
             (26)      Methohexitol;
             (27)      Paraldehyde;
             (28)      Pemoline;
             (29)      Petrichloral;
             (30)      Phentermine;
             (31)      Barbital;
             (32)      Phenobarbital;
             (33)      Meprobamate;
             (34)      Zolpidem;
             (35)      Butorphanol;
             (36)      Modafinil, including its salts, isomers, and salts of isomers;
             (37)      Sibutramine;
             (38)      Zaleplon ;
             (39)    Dichloralphenazone .